ARTICLE | Company News
Genesis Biopharma, SciMeDent Health Corp. deal
December 6, 2010 8:00 AM UTC
SciMeDent (formerly Trend Exploration Inc.) and Genesis mutually terminated a proposed deal granting SciMeDent exclusive, worldwide rights to R-954 to treat painful diabetic neuropathy after SciMeDent...